Schering-Plough (NYSE: SGP) and the EORTC announced that long-term treatment with pegylated interferon alfa-2b in stage III melanoma patients had a significant and sustained impact on relapse-free survival (RFS), according to results of a randomized phase III trial published in The Lancet.

This post is an original post by ScienceDaily: Skin Care News

Posted: July 12th, 2008 under skin health.
Comments: none

A review of 30 years of surveillance and epidemiological records shows that incidence of melonoma, the most lethal form of skin cancer, is increasing among young Caucasian women but not among young men in the US. The reviewers did not establish if this is due to increased exposure to ultraviolet radiation or some other factor and suggested this should be investigated further.

This post is an original post by ScienceDaily: Skin Care News

Posted: July 11th, 2008 under skin health.
Comments: none

Opticom Data Research performs skin mole analysis on mole images that are submitted through its Web site. The company uses its MoleSense software to analyze these moles and then an automated process compares the analysis results to 100s of skin cancer images available on the Internet. This is a new service by Opticom Data Research. A report is emailed to the individual who submitted the mole image.

This post is an original post by ScienceDaily: Skin Care News

Posted: July 11th, 2008 under skin health.
Comments: none

Several specific risk factors have been identified in the recurrence or spreading of cutaneous squamous-cell carcinoma, or skin cancer. These factors, released on July 9, 2008 in The Lancet Oncology, include: a tumor thickness of 6.0 mm or more, desmoplastic growth, location at the ear, and immune suppression. Squamous-cell carcinomas (SCCs) are some of the most likely cancers to metastasize or spread.

This post is an original post by ScienceDaily: Skin Care News

Posted: July 10th, 2008 under skin health.
Comments: none

MISSION Product™, the first Athlete-Engineered Skincare™ line, congratulates five of its athletes as they prepare to represent the United States in Beijing this summer. Only three months after joining forces to help launch MISSION Product, a line of high-performance skincare products specifically designed by athletes to meet athletic needs, U.S.

This post is an original post by ScienceDaily: Skin Care News

Posted: July 9th, 2008 under skin health.
Comments: none

ALIGN Pharmaceuticals, LLC, a wholly owned subsidiary of Cyclacel Pharmaceuticals, Inc., (NASDAQ: CYCC, CYCCP) announced results of a double-blinded, randomized, vehicle-controlled clinical study showing that Xclair® cream (formerly MAS065D) is safe and effective in the treatment and prevention of radiation dermatitis. These results were published in the May-June 2008 issue of the European Journal of Dermatology.

This post is an original post by ScienceDaily: Skin Care News

Posted: July 9th, 2008 under skin health.
Comments: none

The European Commission announced a new 50mg Enbrel® (etanercept) once weekly dosage regimen as an alternative to the currently approved 25mg Enbrel® twice weekly regimen for the treatment of patients with moderate-to-severe plaque psoriasis. Based on the outcome of the extensive European 318 study in adult patients with moderate-to-severe plaque psoriasis, the European Commission issued the marketing authorisation for the European Union for a once weekly 50mg Enbrel® dosing.

This post is an original post by ScienceDaily: Skin Care News

Posted: July 9th, 2008 under skin health.
Comments: none

An analysis of more than 100 patients has confirmed for the first time that darker-skinned patients benefit as those with lighter skin when given light therapy for morphea and related diseases, UT Southwestern Medical Center researchers show. Phototherapy is the use of ultraviolet light to treat skin disorders, ranging from common problems such as acne and psoriasis to rarer conditions such as scleroderma and morphea, a hardening of the skin.

This post is an original post by ScienceDaily: Skin Care News

Posted: July 9th, 2008 under skin health.
Comments: none

They may look like they would do anything for a perma-tan, but new research from iVillage.co.uk has found that women who use fake tan are twice as likely to use sun protection than those who don’t. Despite their desire for a sun-kissed look, 44% of women who wear fake tan say they always use sunscreen, whereas just 21% of women who prefer pale actually protect their skin from the sun.

This post is an original post by ScienceDaily: Skin Care News

Posted: July 8th, 2008 under skin health.
Comments: none

An analysis of more than 100 patients has confirmed for the first time that darker-skinned patients benefit as those with lighter skin when given light therapy for morphea and related diseases, researchers show.

This post is an original post by ScienceDaily: Skin Care News

Posted: July 8th, 2008 under skin health.
Comments: none